Drug intelligence / Profile preview

chloramphenicol + tetracycline + zinc oxide + eugenol

Development stage
Phase 2
Lead developer
Biodinamica Química e Farmacêutica
Modality
Small Molecules
Administration
Topical
01

Overview

This drug is a fixed-dose combination dental paste consisting of chloramphenicol, tetracycline, zinc oxide, and eugenol, primarily indicated for the treatment and prevention of alveolar osteitis (dry socket). Chloramphenicol and tetracycline provide synergistic broad-spectrum antibacterial activity by inhibiting protein synthesis at the 50S and 30S ribosomal subunits, respectively, targeting pathogens common in post-extraction infections. Zinc oxide acts as a mild antiseptic and astringent base that facilitates the formation of a protective physical barrier over the exposed alveolar bone. Eugenol, a clove-derived phenolic compound, provides local analgesic and sedative effects, likely through the inhibition of prostaglandin synthesis and modulation of nerve conduction, effectively managing the acute pain characteristic of dry socket.

Brand names
Alveopen
Other names
chloramphenicol/tetracycline/zinc oxide/eugenolAlveopen dental paste
02

Targets

Bacterial 50S ribosomal subunitBacterial Ribosome

Beyond the preview

Go deeper on chloramphenicol + tetracycline + zinc oxide + eugenol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chloramphenicol + tetracycline + zinc oxide + eugenol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call